The Fractal Resonance Model platform ("FRM", "we", "us", "our") is operated by Neuro-Medtech UK Ltd, a company registered in England and Wales. We act as the Controller (controlador) of your personal data as defined under Brazil's Lei Geral de Proteção de Dados (LGPD, Lei nº 13.709/2018).
In accordance with LGPD Article 41, an Encarregado (Data Protection Officer) will be appointed and their contact details published on this page once designated. In the interim, privacy enquiries may be directed to our general contact below.
The LGPD applies to our processing activities pursuant to Article 3, as we process personal data of individuals located in Brazil, the processing is carried out for the purpose of offering services to individuals in Brazil, and the personal data was collected in Brazilian territory.
Data Controller (Controlador): Neuro-Medtech UK Ltd
3 Janson Court, Reading, RG1 6NA, United Kingdom
Phone: +44 7402 802288
Encarregado (DPO): To be appointed per LGPD Art. 41
This privacy policy applies specifically to the processing of personal data of individuals located in Brazil, in accordance with LGPD Article 3. The LGPD applies when:
This policy should be read alongside our general privacy practices. Where there is a conflict between this policy and local Brazilian law, the provisions that afford greater protection to the data subject (titular) shall prevail.
We collect and process the following categories of personal data, classified under LGPD Article 5:
EEG recordings and neurological analysis results are classified as sensitive personal data (dados pessoais sensíveis) under LGPD Article 5, II. The LGPD imposes stricter requirements for processing such data under Article 11.
We process sensitive health data under the following legal bases:
Under LGPD Article 11, §4, the use of sensitive health data for the purpose of obtaining economic advantage by third parties is prohibited, except in cases of health service provision, pharmaceutical assistance, and health assistance, including ancillary diagnostic and therapeutic services.
Under the LGPD, every processing activity must have a valid legal basis. Below is a summary of the bases we rely on:
| Purpose | Legal Basis (LGPD) | Article |
|---|---|---|
| Account creation and authentication | Performance of contract | Art. 7, V |
| Clinical qEEG analysis and reporting | Explicit consent (sensitive data) | Art. 11, I |
| Health protection by professionals | Health protection | Art. 11, II(f) |
| Platform security and audit logs | Legitimate interest | Art. 7, IX |
| Legal and regulatory compliance | Legal or regulatory obligation | Art. 7, II |
| Scientific and clinical research | Research by research bodies | Art. 11, II(c) / Art. 13 |
We use your personal data for the following purposes, always in accordance with the principles of LGPD Article 6 (purpose, adequacy, necessity, transparency, security, non-discrimination, and accountability):
As Neuro-Medtech UK Ltd is based in the United Kingdom, personal data of Brazilian data subjects is transferred internationally. The LGPD regulates international transfers under Articles 33 to 36.
We rely on the following mechanisms to ensure adequate protection for international transfers:
You have the right to be informed about international transfers and the safeguards applied. We will notify you of any material changes to our transfer mechanisms.
In accordance with LGPD Articles 46 and 47, we implement administrative, technical, and organisational security measures to protect personal data against unauthorised access, accidental or unlawful destruction, loss, alteration, communication, or any form of improper or unlawful processing.
In the event of a security incident that may cause relevant risk or damage to data subjects, we will notify the ANPD and the affected data subjects within a reasonable time, in accordance with LGPD Article 48. The notification will include:
Under LGPD Articles 15 and 16, personal data must be deleted after the end of its processing period, except where retention is required by law or regulation. Brazilian medical records are subject to CFM (Conselho Federal de Medicina) Resolution 1.821/2007, which establishes a minimum retention period of 20 years.
| Data Category | Retention Period | Legal Basis |
|---|---|---|
| Clinical/qEEG records | 20 years minimum | CFM Resolution 1.821/2007 |
| Account data | Duration of account + 5 years | Art. 16, I (legal obligation) |
| Audit logs | 10 years | Art. 16, I (regulatory compliance) |
| Anonymised research data | Indefinite | Art. 12 (not personal data) |
| Consent records | Duration of processing + 5 years | Art. 8, §2 (burden of proof) |
Upon termination of processing, data will be deleted or anonymised, unless retention is authorised under LGPD Article 16 for legal compliance, research (with anonymisation), transfer to third parties (with adequate safeguards), or the exclusive use of the controller in anonymised form.
In accordance with LGPD Articles 26 and 27, we may share personal data with the following categories of recipients:
We do not sell personal data. We do not share personal data for direct marketing purposes. All data sharing is subject to the principles of purpose, adequacy, and necessity (LGPD Art. 6).
The FRM platform uses computational algorithms and AI-assisted analysis for qEEG interpretation. Under LGPD Article 20, you have the right to request a review of decisions made solely on the basis of automated processing that affect your interests.
Important clarifications about our AI processing:
Per LGPD Article 20, §1, if we cannot provide the information due to trade secrets, the ANPD may conduct an audit to verify any discriminatory aspects in automated processing.
Under LGPD Article 18, you (as the data subject / titular) have the following rights, which may be exercised at any time by contacting us:
Under LGPD Article 20, you also have the right to request a review of decisions made solely on the basis of automated processing of personal data that affect your interests, including decisions intended to define your personal, professional, consumer, or credit profile, or aspects of your personality.
Under LGPD Article 18, §1, you have the right to file a complaint with the Autoridade Nacional de Proteção de Dados (ANPD) if you believe your data protection rights have been violated.
The FRM platform uses only essential, functional cookies and browser local storage required for the application to operate. We do not use tracking cookies, advertising cookies, or third-party analytics.
Data stored locally in your browser includes:
This use of cookies and local storage is consistent with the Marco Civil da Internet (Lei 12.965/2014), which governs internet use in Brazil, and the LGPD principles of necessity and purpose limitation.
Under LGPD Article 14, the processing of personal data of children and adolescents must be carried out in their best interest.
For patients under 18 years of age:
The best interest of the child or adolescent will always be the primary consideration in any processing decision involving their personal data, in accordance with LGPD Article 14 and the Estatuto da Criança e do Adolescente (ECA, Lei 8.069/1990).
We may update this privacy policy from time to time to reflect changes in our practices, legal requirements, or ANPD guidance. When we make material changes:
We encourage you to review this policy periodically to stay informed about how we protect your data.
To exercise any of your rights under the LGPD, or for any questions about this privacy policy, you may contact us through the following channels:
Data Controller (Controlador):
Neuro-Medtech UK Ltd
3 Janson Court, Reading, RG1 6NA, United Kingdom
Phone: +44 7402 802288
Encarregado (Data Protection Officer):
To be appointed per LGPD Art. 41
Contact details will be published here once designated.
If you believe your data protection rights have been violated, you have the right to file a complaint with the Autoridade Nacional de Proteção de Dados (ANPD):
Autoridade Nacional de Proteção de Dados (ANPD)
Website: www.gov.br/anpd
Setor Comercial Norte, Quadra 6, Conjunto A, Bloco A, 2º andar
Edifício Venâncio 3.000
CEP 70716-900 — Brasília/DF, Brazil